Rambam Health Care Campus

Haifa, Ḥeifā 3109601

1 studies enrolling now · 7 studies all time

What they study most

Advanced Colorectal Cancer (Part 1), Brain Neoplasms, Brain Neoplasms, Primary, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Glioma, Malignant Melanoma, Malignant Neoplasms, Melanoma, Non-Small-Cell Lung Cancer, Rheumatoid Arthritis, Thyroid Cancer

Studies at this site

• A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. — Recruiting now
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer — Running, not enrolling
• A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement — Stopped early
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes — Completed